Testing for mismatch repair deficiency remains underused among adults with colorectal cancer, despite the existence of well-established guidelines aimed at high-risk populations. READ MORE
A novel scoring system may identify elderly patients with advanced gastric cancer who may not benefit from chemotherapy.
A pilot program for Direct Access Colonoscopy Screening increased overall screening rates for colorectal cancer by nearly 100%.
Costs associated with maintenance bevacizumab and capecitabine.
Testing for mismatch repair deficiency remains underused among adults with colorectal cancer, despite the existence of well-established guidelines aimed at high-risk populations.
People who eat a high-fiber diet or increase their fiber intake after a colon cancer diagnosis may be less likely to die of these tumors than individuals who don’t consume much fiber.
A recent study examined the association between colorectal cancer messenger RNA expression of HER3 with response to anti-EGFR agents.
A pooled analysis investigated the prognostic role of DNA mismatch repair status in patients with stage III colon cancer treated with a standard adjuvant chemotherapy regimen.
Research in Review
A recent study combined and analyzed data from three trials regarding the use of first-line chemotherapy plus selective internal radiotherapy in patients with colorectal cancer and liver metastases.
A majority of older patients with stage II or III rectal adenocarcinoma do not receive standard-of-care treatment.
A recent study compared the effects of first-line chemotherapy with two different drugs in patients with advanced or metastatic colorectal cancer.